Biofrontera (BFRI) Depreciation & Amortization (CF) (2020 - 2025)
Biofrontera (BFRI) recorded quarterly Depreciation & Amortization (CF) of $36000.0 in Q4 2025, up 111.76% quarter-over-quarter from $17000.0 in Q3 2025, and down 5.26% on a YoY basis from $38000.0 in Q4 2024.
Biofrontera (BFRI) Depreciation & Amortization (CF) (2020 - 2025) Analysis & Trends
Biofrontera's Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $36000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) fell 5.26% year-over-year to $36000.0; the TTM figure through Dec 2025 stood at $100000.0 (changed 0.0% YoY), while the FY2025 annual figure was $138000.0, down 67.22% from the prior year.
- Depreciation & Amortization (CF) was $36000.0 for Q4 2025 at Biofrontera, up from $17000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $38000.0 in Q4 2024 to a low of $17000.0 in Q3 2025.
- Historically, Depreciation & Amortization (CF) has averaged $25263.2 across 5 years, with a median of $22000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) retreated 21.21% in 2022, then jumped 80.95% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $29000.0 in 2021, then slipped by 27.59% to $21000.0 in 2022, then changed by 0.0% to $21000.0 in 2023, then surged by 80.95% to $38000.0 in 2024, then slipped by 5.26% to $36000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $36000.0 (Q4 2025), $17000.0 (Q3 2025), and $22000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn | 36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |